July 22, 2024, Cupertino, CA
CARPL.ai, the largest marketplace for radiology AI applications, has recently entered into a strategic partnership with AdvaHealth Solutions, the cloud-native PACS solution provider for AdvaPACS. This collaboration aims to enhance both companies' presence in the global medical imaging market, particularly in the Asia-Pacific (APAC) region, and to offer a comprehensive suite of radiology AI applications to healthcare providers. CARPL.ai’s marketplace includes over 125 AI applications from more than 50 AI companies, spanning all body parts and modalities. When used alongside AdvaPACS’ solutions, CARPL.ai’s marketplace of AI applications will enhance the diagnostic capabilities available to healthcare providers, offering a full spectrum of AI-assisted screening. AdvaPACS is a fully managed SaaS cloud-native PACS with Enterprise Imaging VNA capabilities, empowering medical imaging specialists to diagnose patients using FDA & TGA-approved diagnostic viewers. "By joining forces with AdvaPACS, we aim to augment the value we deliver to the healthcare market, expanding the reach and efficacy of AI-driven medical imaging diagnostics," said Vidur Mahajan, CEO of CARPL.ai. "This partnership aims to meet the growing demand for advanced diagnostic tools across medical practices in the region. Together, we are poised to set new standards in healthcare diagnostics, benefiting providers and patients alike with more accurate and accessible technology." "We are truly excited to collaborate with a market leader like CARPL.ai, and see how our solutions complement their products, so customers can have easier access to a more complete offering in medical imaging AI analysis," said Alan McCarthy, CEO of AdvaPACS. CARPL.ai is an end-to-end enterprise imaging AI platform that helps healthcare providers access, assess, and integrate radiology AI applications into their workflows. This partnership allows any radiologist or healthcare system using ADVA PACS to leverage CARPL.ai's marketplace, significantly enhancing their operational, financial, and clinical ROI. CARPL.ai also offers an FDA-cleared universal AI viewer that allows radiologists to accept, reject, or modify AI outputs. By partnering with CARPL.ai, ADVA PACS users can now access an extensive marketplace to integrate radiology AI applications seamlessly into their workflows. This integration helps healthcare providers realize the value of the encapsulated AI ecosystem, ultimately improving patient care and clinical outcomes. For more information, visit: www.carpl.ai and www.advapacs.com
